in a double-blind cross-over trial in 17 asthmatic patients with reversible airway obstruction inhalation of both fenoterol ( 0.4 mg ) and terbutaline ( 0.5 mg ) produced a statistically significant greater increase in peak expiratory flow rate than did placebo .
C0004096
asthmatic
C0039542
terbutaline